15.09.2017 Zugemailt von / gefunden bei: RCB (BSN-Hinweis: Lauftext im Original des Aussenders, Titel (immer) und Bebilderung (oft) durch boerse-social.com aus dem Fotoarchiv von photaq.com) ...

... AGRANA cut to HOLD, TP EUR 114.5 - Facing reality of low prices - earnings estimates cut by 34% in 2/2019e and by 33% in 2/2020e- global sugar prices have been collapsing and bioethanol prices are falling too- target price lowered to EUR 114.5 (from EUR 136.0)- Rating cut to HOLD (from BUY)- AGRANA´s EV/EBITDA of 9.4x for 2018e is in line with the sector median nowWe think that AGRANA is a very well-managed company offering growth across the cycle, strong free cash flows and a shareholder-friendly dividend policy. Nevertheless, we downgrade AGRANA to HOLD (from BUY) because we reckon that the earnings of the group will be at an inflection point after the release of very strong 2Q 17/18e results, scheduled for October 12. We now forecast much lower earnings and cash flows in 2018/19e and 2019/20e due to the ongoing weakness of global sugar prices and the decline of the price for bioethanol. Moreover we think that the potential acquisition of any Serbian sugar assets will have a much smaller positive impact on our earnings projections.Falling prices for sugar and bioethanol: Since the beginning of 2017 global sugar prices have been in decline mode, which in turn is due to the expectation that the global sugar market will be in imbalance (supplies in excess of demand) going forward leading to higher inventories. We find it hard to predict when the global sugar price is likely to recover, but for the time being we assume it will remain on such a low level during until mid-2018e. At present the European prices of bioethanol are hovering around the level of EUR 530/cbm, which is in line with the average level of prices since the beginning of 2016. We estimate that AGRANA´s own bioethanol activities are profitable above the EUR 500/cbm price mark, which means this business is currently still in positive territory albeit lower in comparison to recent quarters.Earnings revisions: On balance we keep our 2017/18e earnings estimates unchanged but cut our net profit estimates by 34% for 2018/19e and by 33% for 2019/20e. This, in turn, is due to the following new assumptions: 1) a 20% yoy decline of realised prices and gross profit in the Sugar segment, 2) a similar decline of prices for isoglucose, a business which represents 15% of the Starch segment and 3) lower income from associates from HUNGRANA given the current weakening of European prices for bioethanol. In light of the current weak development of the global sugar price we think that the potential acquisition of any Serbian sugar assets if concluded will have a much smaller impact on our earnings projections than so far projected.Growth investments: The current capex initiatives of the group include the addition of two further lines to its fruit preparations business in the USA and France. Moreover the group plans to build a second fruit preparations plant in China with a capacity of 30k tons. Elsewhere the company also decided to enlarge its existing potato starch facility in Gmünd/Austria for EUR 40 mn and the wheat starch capacity in Pischelsdorf/Austria for EUR 92 mn. We believe these expansion plans will support additional growth for the Starch and Fruit segments over the medium term, which we think is the right strategy and we continue to see this as a positive development. Company im Artikel Agrana Platz 5 im Umsatzranking YTD in . Stephan Büttner (CFO) Johann Marihart (CEO) Hannes Haider (IR) Thomas Kölbl (Board Member) Fritz Gattermayer (Board Member) Für Zusatzliquidität im Orderbuch der Agrana-Aktien sorgen die Raiffeisen Centrobank AG als Specialist sowie die Market Maker Hauck & Aufhäuser und Oddo Seydler Bank AG, Klick auf Institut/Bank öffnet Übersicht. Agrana 7711 downgrade_fur_agrana

Christian Drastil: Wiener Börse Plausch

Börsepeople im Podcast S2/13: Gregor Rosinger

Bildnachweis

1. Agrana   >> Öffnen auf photaq.com

Random Partner

---

S&T AG
Der Technologiekonzern S&T AG ist mit rund 6.300 Mitarbeitern und Niederlassungen in mehr als 30 Ländern weltweit präsent. Das im TecDAX® und SDAX® an der Deutschen Börse gelistete Unternehmen ist einer der führenden Anbieter von IoT (Internet of Things) Technologien. In diesen Bereichen konzentriert sich S&T auf die Entwicklung sicherer und vernetzter Lösungen durch ein kombiniertes Portfolio aus Hardware, Middleware und Services. Eigentechnologien in den Bereichen Smart Factory, Zugfunksysteme, Medizintechnik, Kommunikationslösungen und Smart Energy sowie ein breites Portfolio an IT-Dienstleistungen machen S&T zu einem gefragten Partner für Kunden unterschiedlichster Branchen.

>> Besuchen Sie 64 weitere Partner auf boerse-social.com/partner

Agrana